| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 5,194 | 5,184 | 4,735 | | Cost of Revenue | 1,858 | 2,045 | 2,019 | | | Gross Profit | 3,336 | 3,139 | 2,716 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,036 | 2,002 | 1,835 | | Non Recurring |
-
|
-
|
-
| | Others | 59 | 80 | (4) | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,240 | 1,057 | 885 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,240 | 1,057 | 885 | | Interest Expense | 800 | 958 | 687 | | Income Before Tax | 441 | 99 | 199 | | Income Tax Expense | 171 | 28 | 79 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 270 | 71 | 119 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 270 | 71 | 119 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $270 | $71 | $119 |
|
0.49% Nasdaq 
Income Statement
